• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Notable Response of SMARCA4-Deficient Undifferentiated Uterine Sarcoma to Palliative Radiation Therapy.

作者信息

Kurokawa Mariko, Shimizuguchi Takuya, Ito Kei, Takao Maki, Motoi Toru, Taguchi Ayumi, Yasugi Toshiharu, Karasawa Katsuyuki

机构信息

Departments of Radiation Oncology.

Radiology.

出版信息

Adv Radiat Oncol. 2021 May 25;6(5):100728. doi: 10.1016/j.adro.2021.100728. eCollection 2021 Sep-Oct.

DOI:10.1016/j.adro.2021.100728
PMID:34258477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8256183/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68db/8256183/a6291bd9454a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68db/8256183/b8c72873ce23/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68db/8256183/a6291bd9454a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68db/8256183/b8c72873ce23/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68db/8256183/a6291bd9454a/gr2.jpg

相似文献

1
Notable Response of SMARCA4-Deficient Undifferentiated Uterine Sarcoma to Palliative Radiation Therapy.SMARCA4缺陷型未分化子宫肉瘤对姑息性放射治疗的显著反应
Adv Radiat Oncol. 2021 May 25;6(5):100728. doi: 10.1016/j.adro.2021.100728. eCollection 2021 Sep-Oct.
2
-deficient Undifferentiated Uterine Sarcoma: Clinicopathological Features of an Emerging Entity.- 缺乏特定特征的未分化子宫肉瘤：一种新出现实体的临床病理特征
Int J Surg Pathol. 2023 Feb;31(1):104-109. doi: 10.1177/10668969221095266. Epub 2022 Apr 24.
3
Infrequent loss of SMARCA4, SMARCA2, and SMARCB1 expression in uterine mesenchymal tumors.子宫间质肿瘤中 SMARCA4、SMARCA2 和 SMARCB1 表达缺失不常见。
Hum Pathol. 2021 Oct;116:12-21. doi: 10.1016/j.humpath.2021.07.001. Epub 2021 Jul 13.
4
SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation association.SMARCA4 失活定义了具有横纹肌样和小细胞特征以及种系突变关联的未分化子宫肉瘤亚群。
Mod Pathol. 2019 Nov;32(11):1675-1687. doi: 10.1038/s41379-019-0303-z. Epub 2019 Jun 12.
5
Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma.SMARCA4 缺陷型未分化子宫肉瘤的病理特征和免疫微环境。
Diagn Pathol. 2023 May 16;18(1):62. doi: 10.1186/s13000-023-01347-3.
6
SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma.SMARCA4 缺陷型未分化子宫肉瘤（子宫恶性横纹肌样瘤）：一种与未分化癌不同的临床病理实体。
Mod Pathol. 2018 Sep;31(9):1442-1456. doi: 10.1038/s41379-018-0049-z. Epub 2018 Apr 26.
7
The value of SOX2 in the differential diagnosis of SMARCA4 (BRG1)-deficient uterine neoplasms.SOX2 在鉴别诊断 SMARCA4（BRG1）缺陷型子宫肿瘤中的价值。
Hum Pathol. 2022 Jun;124:45-55. doi: 10.1016/j.humpath.2022.03.009. Epub 2022 Mar 22.
8
SMARCA4-deficient Uterine Sarcoma and Undifferentiated Endometrial Carcinoma Are Distinct Clinicopathologic Entities.SMARCA4 缺陷型子宫肉瘤和未分化子宫内膜癌是两种不同的临床病理实体。
Am J Surg Pathol. 2020 Feb;44(2):263-270. doi: 10.1097/PAS.0000000000001375.
9
Germline mutations of SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type and in SMARCA4-deficient undifferentiated uterine sarcoma: Clinical features of a single family and comparison of large cohorts.胚系 SMARCA4 突变在卵巢小细胞癌、高钙血症型和 SMARCA4 缺陷型未分化子宫肉瘤中的作用：一个家族的临床特征及与大样本队列的比较。
Gynecol Oncol. 2020 Apr;157(1):106-114. doi: 10.1016/j.ygyno.2019.10.031. Epub 2020 Jan 15.
10
A case of radio-insensitive SMARCA4-deficient thoracic undifferentiated carcinoma with severe right heart failure.一例对放疗不敏感的SMARCA4缺陷型胸段未分化癌伴严重右心衰竭。
Respir Med Case Rep. 2021 Feb 18;32:101364. doi: 10.1016/j.rmcr.2021.101364. eCollection 2021.

引用本文的文献

1
SMARCA4-deficient undifferentiated uterine sarcoma: A case report and literature review.SMARCA4缺陷型未分化子宫肉瘤：一例病例报告及文献综述
Medicine (Baltimore). 2025 Aug 15;104(33):e43828. doi: 10.1097/MD.0000000000043828.
2
SMARCA4-deficient uterine tumors in young women: response to immune checkpoint inhibitors.年轻女性中SMARCA4缺陷型子宫肿瘤：对免疫检查点抑制剂的反应
Int Cancer Conf J. 2024 Sep 17;13(4):515-519. doi: 10.1007/s13691-024-00721-2. eCollection 2024 Oct.
3
SMARCA4‑deficient uterine adnexal tumor with ascites: A case report and literature review.

本文引用的文献

1
SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas.SMARCA4 缺陷型胸肉瘤样肿瘤主要为与吸烟相关的未分化癌，而非原发性胸肉瘤。
J Thorac Oncol. 2020 Feb;15(2):231-247. doi: 10.1016/j.jtho.2019.10.023. Epub 2019 Nov 18.
2
SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation association.SMARCA4 失活定义了具有横纹肌样和小细胞特征以及种系突变关联的未分化子宫肉瘤亚群。
Mod Pathol. 2019 Nov;32(11):1675-1687. doi: 10.1038/s41379-019-0303-z. Epub 2019 Jun 12.
3
伴有腹水的SMARCA4缺陷型子宫附件肿瘤：一例报告及文献复习
Oncol Lett. 2024 Jun 5;28(2):357. doi: 10.3892/ol.2024.14490. eCollection 2024 Aug.
4
SMARCA4-Deficient Undifferentiated Tumor of the Esophagus: Diagnostic Pitfalls in Immunohistochemical Profiles.SMARCA4 缺陷性食管未分化肿瘤：免疫组织化学特征中的诊断陷阱。
Int J Surg Pathol. 2024 Oct;32(7):1292-1302. doi: 10.1177/10668969241228290. Epub 2024 Mar 18.
Targeting of BRM Sensitizes -Mutant Lung Cancer Cell Lines to Radiotherapy.
靶向 BRM 使 - 突变肺癌细胞系对放射治疗敏感。
Mol Cancer Ther. 2019 Mar;18(3):656-666. doi: 10.1158/1535-7163.MCT-18-0067. Epub 2018 Nov 26.
4
SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma.SMARCA4 缺陷型未分化子宫肉瘤（子宫恶性横纹肌样瘤）：一种与未分化癌不同的临床病理实体。
Mod Pathol. 2018 Sep;31(9):1442-1456. doi: 10.1038/s41379-018-0049-z. Epub 2018 Apr 26.
5
SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior.SMARCA4 缺陷性胸壁肉瘤：一种具有未分化横纹肌样形态和侵袭性行为的独特临床病理实体。
Mod Pathol. 2017 Oct;30(10):1422-1432. doi: 10.1038/modpathol.2017.61. Epub 2017 Jun 23.
6
Phase I trial of radiation therapy and sorafenib in unresectable liver metastases.放射治疗与索拉非尼用于不可切除肝转移瘤的I期试验
Radiother Oncol. 2017 May;123(2):234-239. doi: 10.1016/j.radonc.2017.01.018. Epub 2017 Feb 13.
7
A genetic basis for the variation in the vulnerability of cancer to DNA damage.癌症对 DNA 损伤易感性的遗传基础。
Nat Commun. 2016 Apr 25;7:11428. doi: 10.1038/ncomms11428.
8
SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer.SMARCA4/BRG1是一种新型预后生物标志物，可预测切除的非小细胞肺癌中基于顺铂化疗的结果。
Clin Cancer Res. 2016 May 15;22(10):2396-404. doi: 10.1158/1078-0432.CCR-15-1468. Epub 2015 Dec 15.
9
Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases.卵巢高钙血症型小细胞癌（SCCOHT）：47例病例综述
Gynecol Oncol. 2016 Jan;140(1):53-7. doi: 10.1016/j.ygyno.2015.11.004. Epub 2015 Nov 4.
10
Biology and Treatment of Rhabdoid Tumor.横纹肌样瘤的生物学特性与治疗
Crit Rev Oncog. 2015;20(3-4):199-216. doi: 10.1615/critrevoncog.2015013566.